Nektar Therapeutics - Company Profile
Powered by
All the data and insights you need on Nektar Therapeutics in one report.
- Save hours of research time and resources with
our up-to-date Nektar Therapeutics Strategy Report
- Understand Nektar Therapeutics position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Nektar Therapeutics (Nektar) develops new drugs based on its PEGylation and advanced polymer conjugation technology platforms. Its focus on research and development activities, proprietary technology and strategic partnerships are its strengths, even as significant operating losses is a cause for concern. The company could benefit from its product pipeline, demographic trends, and strategic collaborations in the US. Nevertheless, its performance could be affected by government regulations, competitive environment in the industry and increased pricing control.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer